Rufinamide plus ASMs vs other ASM plus ASMs
Number of adverse events requiring discontinuation of treatment ‐ not reported · Lennox‐Gastaut syndrome, any age
Rufinamide plus ASMs showed no clear difference in number of participants with treatment‐emergent adverse events… compared with other ASM plus ASMs (low certainty).
1 finding from 1 review
- RR 0.96 [0.1, 9.57]1 study · 37 participantsLow